Report of a case with gallbladder carcinoma: P53 expression of the peritumor epithelium might predict biliary tract recurrence  by Takano, Atsushi et al.
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INTRODUCTION:  The  over-expression  of  P53  protein  in  gallbladder  carcinoma  is  a biomarker  correlating
with  a poor  survival.  However,  the  signiﬁcance  of  P53  expression  in  peritumor  tissues  is unknown.  We
experienced  a case  of  gallbladder  carcinoma  where  the  operative  specimen  showed  over-expression  of
P53  on  the peritumor  epithelium,  and  early  recurrence  developed  at the biliary  tract.
PRESENTATION  OF  CASE:  A  74-year-old  female  patient  was  referred  to our  hospital  due  to  wall  thickening  of
the gallbladder  on  ultrasonography.  Radiographic  examinations  revealed  wall  thickening  at  the  fundus
of gallbladder  and  no  abnormalities  of  the biliary  tract  or surrounding  lymph  nodes.  We  performed
open  cholecystectomy  and  lymph  node  dissection  without  extrahepatic  bile  duct  resection,  as a frozen
section  of  the  surgical  stump  of the  cystic  duct  was cancer-free.  However,  a  pathological  examination
revealed  over-expression  of  P53  protein  in the epithelium  of  the  peritumor  to  the  cystic  duct,  which  were
diagnosed  as  normal  on  hematoxylin  eosin  staining.
The  patient  developed  bile  duct  metastases,  two and  half years  after  the  operation.  She underwent
endoscopic  stenting  for the obstruction  of  bile  duct  with  no additional  therapy,  and  died  6  months  later.
DISCUSSION  AND  CONCLUSION:  The  immunohistochemical  staining  of the  GB  wall  or  surgical  stump  for  a
surgical  specimen  of  GBC  may  be crucial  to predict  the bile  duct  recurrence.
© 2016  The  Author(s).  Published  by  Elsevier  Ltd  on behalf  of IJS  Publishing  Group  Ltd.  This  is  an  open
he  CCaccess  article  under  t
. Introduction
The incidence of gallbladder and bile duct cancer in Japan was
pproximately 21,000 in 2011, and the cancer mortality was  18,000
n 2014 [1]. The prognosis of gallbladder carcinoma (GBC) is poor
ompared with other bile duct cancers, and the 5-year survival rate
f surgical resection is reported to be 40% [2].
However, the carcinogenesis of GBC has not yet been fully elu-
idated, and recent advancements in next-generation sequencing
NGS) analyses have revealed potentially inﬂuential mutated genes
n GBC [3]. Among these genes, the signiﬁcance of P53 mutation has
een intensively evaluated [4,5].
TP53 is a tumor suppressor gene and its mutations are fre-
uently observed in various cancer, such as colon cancer [6], breast
ancer [7], and biliary cancer [3]. The overexpression of P53 protein
∗ Corresponding author at: 1-1-1 Fujimi Kofu Yamanashi 400-8506 Japan.
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210-2612/© 2016 The Author(s). Published by Elsevier Ltd on behalf of IJS Publishing 
reativecommons.org/licenses/by-nc-nd/4.0/). BY-NC-ND  license  (http://creativecommons.org/licenses/by-nc-nd/4.0/).
has been examined by immunohistochemical staining and found to
correlate with poor survival [8,9]. However, the signiﬁcance of P53
expression in peritumor tissues is unknown.
We  herein report a case of GBC where the operative specimen
of peritumor epithelium showed overexpression of P53, and early
recurrence developed at the biliary tract. This case raised the issue
of dealing with precancerous lesions of the gallbladder.
The work has been reported in line with the SCARE criteria [10].
2. Case presentation
A 74-year-old female patient was referred to our hospital due
to wall thickening of the gallbladder on ultrasonography (US).
She underwent a health checkup program including abdominal
US every year, and no diseases had been detected. The physical
examination and laboratory data showed no abnormal ﬁndings at
admission.
Abdominal computed tomography (CT) revealed wall thicken-
ing at the fundus of the gallbladder, which was  well contrasted
Group Ltd. This is an open access article under the CC BY-NC-ND license (http://
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Fig. 1. Abdominal CT, A (axial section) and B (coronal section) indicated wall thickening at the fundus of the gallbladder, which was  well contrasted, and no abnormalities
of  the biliary tract or surrounding lymph nodes.
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wig. 2. A; Abdominal US showed wall thickening of the fundus and a well-deﬁned m
allbladder and common bile duct.
Fig. 1A and B), and no abnormalities of the biliary tract or sur-
ounding lymph nodes.
Additionally, abdominal US showed wall thickening of the fun-
us and a well-deﬁned margin of the gallbladder (Fig. 2A). Magnetic
esonance imaging (MRI) showed no abnormal ﬁndings at the body
o neck of the gallbladder and common bile duct (Fig. 2B). Pancre-
ticobiliary maljunction was not observed.
These ﬁndings suggested a diagnosis of gallbladder carcinoma
ather than adenomyomatosis or other benign diseases. Therefore,
e selected open laparotomy for cholecystectomy. The frozen sec-ion of the tumor conﬁrmed the diagnosis of gallbladder carcinoma
nd no cancerous lesion at the stump of the cystic duct. We  per-
ormed lymph node dissection of the hepato-duodenal ligament
ithout extrahepatic bile duct resection. of the gallbladder. B; MRI  showed no abnormal ﬁndings at the body to neck of the
Macroscopic ﬁndings showed wall thickening of the fundus of
the gallbladder, and a normal mucosal layer of the body to neck
(Fig. 3A and B).
The GBC was diagnosed as well-differentiated carcinoma (Grade
1) (Fig. 4A) measuring 4 × 3 cm,  with transmural invasion (T2) and
no lymph node metastases (N0) indicating stage II of AJCC crite-
ria [11]. P53 protein expression was  observed in the cancer cells
(Fig. 3B) and in the epithelium of the peritumor to the cystic duct
(Fig. 4D), which were diagnosed as normal on HE staining (Fig. 4C).
Although, we  discussed with the patient to undergo the addi-
tional surgery of hepatectomy according to the pathological
diagnosis of T2 GBC, the patients denied the reoperation. We
decided to conduct a careful follow-up, given the diagnosis of
the surgical stump of the cystic duct as tumor-free. However,
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Fig. 3. A and B; Macroscopic ﬁndings showed wall thickening of the fundus of the gallbladder, and a normal mucosal layer of the body to neck.
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aig. 4. A; GBC was  diagnosed as well-differentiated carcinoma, (HE ×40), B P53. Pro
o  the cystic duct were diagnosed normal on HE staining (×100) D; TP53 expression
he patient developed bile duct recurrence after 2.5 years after
he surgery. She was admitted to our hospital due to the sud-
en onset of jaundice, and MRI  revealed the wall thickness of
ile duct indicating bile duct metastasis. And Magnetic Resonance
holangiopancreatography (MRCP) showed dilated hepatic duct
nd irregular stenosis of bile duct (Fig. 5). Although, the patient
nderwent endoscopic stenting for the obstruction of bile duct, she
enied additional therapy, and died 6 months later.. Discussion
The screening program for hepatobillary morbidity using
bdominal US has been widely used in Japan for several decadespression was  observed in the cancer cells (×40), C; the epithelium of the peritumor
observed at peritumor epithelium to cystic duct. (×100).
[12], Consequently, the frequency of incidental gallbladder carci-
noma diagnosed during laparoscopic surgery for benign diseases is
increasing [13,14]. However, the prognosis for patients with GC has
not improved [15].
There are several prognostic factors associated with the recur-
rence of GBC: lymph node metastasis [15], depth of tumor invasion,
histological grade, and perineural invasion [16–19]. However,
superﬁcial cancer spread from the main tumor has also been
reported to be an independent predictive factor for a poor prognosis
[20].
The clinical signiﬁcance of extra-hepatic bile duct resection
(EHBDR) in radical surgery has been extensively discussed, but
this surgery was found to be not associated with an increased
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[
[17] Y. Shirai, K. Yoshida, K. Tsukada, T. Muto, H. Watanabe, Early carcinoma of the
gallbladder, Eur. Journal Surg. Acta chirurgica 158 (10) (1992) 545–548.Fig. 5. MRCP showed dilated hepatic duct and irregular stenosis of bile duct.
urvival rate [21,22]. EHBDR should be selectivity performed only
n speciﬁc cases, such as GC with extrahepatic bile duct invasion.
 multi-center questionnaire survey by the Japanese Society of Bil-
ary Surgery [23] concluded that EHBDR may  be unnecessary in
dvanced GC without direct inﬁltration of the hepatoduodenal lig-
ment and the cystic duct.
The signiﬁcance of P53 immunostaining for GBC had been
eported over the past several decades. Kamel et al. hypothesized
hat, assuming p53 expression is an early event in the carcinogen-
sis of a group of GCs, p53-positive dysplasias evolve to a more
ggressive type of tumor, which would be indicated by association
ith high tumor grade and Ki67 positivity [24].
Few studies have so far examined the P53 protein expression
f the normal epithelium of the gallbladder. Shu et al. reported
hat the p53 expression of GBC, peritumor tissue, and benign dis-
rder (cholecystitis) was 50%, 30%, and 5%-10%, respectively [25].
n addition, Katabi et al. reported P53 immunoexpression of 80% in
arcinoma (4/5), 25% in metaplasia (2/8), and 0% in normal epithe-
ium (0/21) [26], indicating that P53 expression occurs late in biliary
arcinogenesis and highlights the sequence of tumor progression
rom metaplasia to carcinoma.
The present case showed that immunostaining for P53 expres-
ion is necessary to predict the carcinogenesis of the remnant
ile duct. Even though the surgical stump of the cystic duct was
iagnosed as tumor-free by HE staining as the present case, P53
xpression was still observed. We  should consider additional pro-
hylactic bile duct resection.
The immunohistochemical staining of P53 for a surgical speci-
en  of GBC may  be crucial to predict the bile duct recurrence.
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